Docosahexaenoic acid intake ameliorates ketamine-induced impairment of spatial cognition and learning ability in ICR mice
Docosahexaenoic acid intake ameliorates ketamine-induced impairment of spatial cognition and learning ability in ICR mice
复制标题
二十二碳六烯酸摄入可改善氯胺酮引起的 ICR 小鼠空间认知和学习能力损伤
DOI:
10.1016/j.neulet.2014.08.011
复制
发表时间:
2014-09-19
影响因子:
2.5
通讯作者:
Chen, Hongxian
中科院分区:
文献类型:
--
作者:
Huang, Shucai;Dai, Yuanyuan;Chen, Hongxian
Several studies have reported the ketamine-induced cognitive impairment. Docosahexaenoic acid (DHA) supplementation improves cognitive function in human infants and protects against learning impairment in patients with Alzheimer's disease (AD). In this study, we investigated the effect of DMA on ketamine-induced impairment of spatial cognition and learning ability in Institute of Cancer Research (ICR) mice. Morris water maze (MWM) was used to assess spatial learning and memory. Gamma-aminobutyric acid (GABA) levels in the hippocampus and prefrontal cortex were measured using high-performance liquid chromatography (HPLC). The results showed that intraperitoneal injection of ketamine (30 mg/kg, twice per day) for 4 weeks led to the decline of spatial cognitive ability in mice, and 420 mg/(kg d) DMA supplementation for 6 weeks improved ketamine-induced spatial cognitive impairment to a certain extent. The up-regulation of GABA levels in the hippocampus and prefrontal cortex was related to the improvement in spatial learning. Our results suggested that DHA supplementation would be a promising intervention to improve ketamine-induced spatial memory and cognitive dysfunction, and this effect of DHA might be correlated with the up-regulation of GABA levels. (C) 2014 Elsevier Ireland Ltd. All rights reserved.